Table 3 Radiologic response after completion of neoadjuvant therapy for patients with pancreatic adenocarcinoma

0%

11%

77%

11%

[0–0%]

[8–16%]

[62–89%]

[4–19%]

I ^{2 =} 0%

I ² = 10.6%

I ² = 85.12%

I ² = 82.31%

(n = 8)

(n = 8)

(n = 9)

(n = 11)

1%

20%

56%

19%

[0–4%]

[8–35%]

[47–64%]

[11–28%]

I ² = 52.03%

I ² = 84.28%

I ² = 33.25%

I ² = 58.95%

(n = 8)

(n = 8)

(n = 8)

(n = 9)

1%

28%

48%

20%

[0–3%]

[21–35%]

[38–58%]

[13–29%]

I ² = 57.02%

I ² = 82.61%

I ² = 88.09%

I ² = 89.43%

(n = 17)

(n = 19)

(n = 17)

(n = 18)

0%

20%

59%

14%

[0–1%]

[11–31%]

[49–69%]

[8–22%]

I ² = 7.57%

I ² = 84.70%

I ² = 76.89%

I ² = 72.59%

(n = 16)

(n = 16)

(n = 16)

(n = 16)

0%

20%

59%

16%

[0–1%]

[16–25%]

[54–65%]

[12–20%]

I ² = 38.25%

I ² = 81.52%

I ² = 85.12%

I ² = 82.84%

(n = 52)

(n = 56)

(n = 56)

(n = 62)